Silo Pharma, Inc.
Research Silo Pharma, Inc. (SILO) on Bullrun: market cap USD 1.33M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSILO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.33M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 832.83K
- Free cash flow-USD 731.87K
Valuation Snapshot
latest market cap is USD 1.33M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 72.10K | -USD 4.23M | -USD 5.24M | 38.6% | -7.5 | USD 4.75M | n/a | USD 6.31M |
| FY2024 | USD 72.10K | -USD 4.39M | -USD 3.83M | 91.9% | -17.85 | USD 3.91M | n/a | USD 5.03M |
| FY2023 | USD 72.10K | -USD 3.70M | -USD 3.22M | 91.9% | -18 | USD 3.52M | n/a | USD 6.18M |
| FY2022 | USD 72.10K | -USD 3.91M | -USD 3.50M | 91.9% | -25.65 | USD 11.37M | n/a | USD 10.34M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 1.33M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.53M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.99M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 67.15M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 158.20M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 211.57M | n/a | n/a | n/a |
About Silo Pharma, Inc.
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Silo Pharma, Inc.'s market cap?
Silo Pharma, Inc.'s market capitalization is USD 1.33M.
What does Silo Pharma, Inc. do?
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.